Financing Essential HIV Services: A New Economic Agenda
article has not abstract
Vyšlo v časopise:
Financing Essential HIV Services: A New Economic Agenda. PLoS Med 10(12): e32767. doi:10.1371/journal.pmed.1001567
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001567
Souhrn
article has not abstract
Zdroje
1. LozanoR, NaghaviM, ForemanK, LimS, ShibuyaK, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095–2128.
2. UNAIDS (2012) Global report: UNAIDS report on the global AIDS epidemic 2012. Geneva: UNAIDS.
3. WHO (2011) Progress in scale-up of male circumcision for HIV prevention in Eastern and Southern Africa: focus on service delivery - 2011. Geneva: World Health Organization.
4. SeeleyJ, WattsCH, KippaxS, RussellS, HeiseL, et al. (2012) Addressing the structural drivers of HIV: a luxury or necessity for programmes? J Int AIDS Soc 15 Suppl 1: 1–4.
5. SchwartländerB, StoverJ, HallettT, AtunR, AvilaC, et al. (2011) Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 377: 2031–2041.
6. Lule E, Haacker M (2012) The fiscal dimension of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda. Washington (D.C.): The World Bank.
7. UNAIDS (2012) Together we will end AIDS. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS).
8. HellerPS (2006) The prospects of creating ‘fiscal space’ for the health sector. Health Policy Plan 21: 75–79.
9. Drummond P, Daal W, Srivastava N, Oliveira LE (2012) Mobilizing revenue in Sub-Saharan Africa: empirical norms and key determinants. Washington (D.C.): International Monetary Fund.
10. WHO (2013) Global Health Expenditure Database. Geneva: World Health Organization. Available: http://apps.who.int/nha/database/PreDataExplorer.aspx?d=1. Accessed 11 April 2013.
11. International Monetary Fund (2011) Revenue mobilization in developing countries. Fiscal affairs department, international monetary fund (IMF). Washington (D.C.): International Monetary Fund.
12. ReschS, KorenrompE, StoverJ, BlakleyM, KrubinerC, et al. (2011) Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One 6: e25310 doi:10.1371/journal.pone.0025310.
13. Leach-KemonK, ChouDP, SchneiderMT, TardifA, DielemanJL, et al. (2012) The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries. Health Aff (Millwood) 31: 228–235.
14. Lancet (2013) Health and the post-2015 development agenda. Lancet 381: 699.
15. HechtR, StoverJ, BollingerL, MuhibF, CaseK, et al. (2010) Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31. Lancet 376: 1254–1260.
16. World Health Organization (2010) The World Health Report: health systems financing: the path of universal coverage. Geneva: World Health Organization.
17. LuC, SchneiderMT, GubbinsP, Leach-KemonK, JamisonD, et al. (2010) Public financing of health in developing countries: a cross-national systematic analysis. Lancet 375: 1375–1387.
18. GFATM (2011) Policy on eligibility criteria, counterpart financing requirements, and prioritization of proposals for funding from the global fund. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria.
19. PEPFAR (2009) Guidance for PEPFAR Partnership Frameworks and Partnership Framework Implementation Plans, Version 2.0. Washington (D.C.): United States President's Emergency Plan for AIDS Relief.
20. Vassall A, Remme M, Watts C (2012) Social policy interventions to enhance the HIV/AIDS response in Sub-Saharan Africa. Lomborg B, editor. Rethink HIV: smarter ways to invest in ending HIV in Sub-Saharan Africa. Cambridge: Cambridge University Press.
21. AtunR, KnaulFM, AkachiY, FrenkJ (2012) Innovative financing for health: what is truly innovative? Lancet 380: 2044–2049.
22. Partners Advisory (2011) Tax on financial transactions - an implementation guide. Geneva: UNITAID.
23. AtunR, JaffarS, NishtarS, KnaulFM, BarretoML, et al. (2013) Improving responsiveness of health systems to non-communicable diseases. Lancet 381: 690–697.
24. AmicoP, AranC, AvilaC (2010) HIV spending as a share of total health expenditure: an analysis of regional variation in a multi-country study. PLoS One 5: e12997 doi:10.1371/journal.pone.0012997
25. Durairaj V, Evans DB (2010) Fiscal space for health in resource poor countries. World health report. Geneva: World Health Organization.
26. RemmeM, VassallA, LutzB, WattsC (2012) Paying girls to stay in school: a good return on HIV investment? Lancet 379: 2150.
27. TravisP, BennettS, HainesA, PangT, BhuttaZ, et al. (2004) Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet 364: 900–906.
28. JohanssonP, TillgrenP (2011) Financing intersectoral health promotion programmes: some reasons why collaborators are collaborating as indicated by cost-effectiveness analyses. Scand J Public Health 39: 26–32.
29. ZengW, ShepardDS, ChilingerianJ, Avila-FigueroaC (2012) How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries. BMC Health Serv Res 12: 74.
30. Izazola-LiceaJA, WiegelmannJ, AranC, GuthrieT, De LayP, et al. (2009) Financing the response to HIV in low-income and middle-income countries. J Acquir Immune Defic Syndr 52 Suppl 2: S119–126.
31. JaffarS, AmuronB, FosterS, BirungiJ, LevinJ, et al. (2009) Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 374: 2080–2089.
32. IMF (2012) International Monetary Fund World Economic Outlook Database. Available: http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/weoselgr.aspx. Accessed 11 April 2013.
33. UNAIDS (2013) UNAIDS AIDSinfo online database. Available: http://www.aidsinfoonline.org/devinfo/libraries/aspx/Home.aspx. Accessed 11 April 2013.
34. World Bank (2013) World Bank's World Development Indicators Database. Available: http://data.worldbank.org/indicator. Accessed 11 April 2013.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 12
- Statinová intolerance
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Artemisinin Combination Therapy: A Good Antimalarial, but Is the Dose Right?
- Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and Validation
- Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
- Malaria and Severe Anemia: Thinking beyond